Furthermore, Arnau-Barres I et al. (2021) evaluated the impact of serum ALB levels on COVID-19-related in-hospital mortality adjusted for potential confounders, reporting that deceased patients were older, had more comorbidities, higher inflammatory status, and lower serum albumin levels at time of hospitalization (3.10 g/dL (0.51) vs. 3.45 g/dL (0.45); p < 0.01). The gene discussed is ALB; the disease is COVID-19.